Drug Type Small molecule drug |
Synonyms MPS, Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate + [10] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (18 May 1959), |
Regulation- |
Molecular FormulaC26H34NaO8 |
InChIKeyWOARBZBOZOGFGA-SGJOWKDISA-N |
CAS Registry2375-03-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Addison Disease | China | 01 Jan 2001 | |
Anemia | China | 01 Jan 2001 | |
Asthma | China | 01 Jan 2001 | |
Dermatomyositis | China | 01 Jan 2001 | |
Pemphigus | China | 01 Jan 2001 | |
acute spinal cord injury | Japan | 02 Jul 1997 | |
Shock, Septic | Japan | 09 Jan 1982 | |
Renal transplant rejection | Japan | 27 Aug 1979 | |
Shock, Hemorrhagic | Japan | 27 Aug 1979 | |
Anaphylaxis | United States | 18 May 1959 | |
Endocrine System Diseases | United States | 18 May 1959 | |
Eye Diseases | United States | 18 May 1959 | |
Gastrointestinal Diseases | United States | 18 May 1959 | |
Hematologic Diseases | United States | 18 May 1959 | |
Kidney Diseases | United States | 18 May 1959 | |
Neoplasms | United States | 18 May 1959 | |
Respiratory Diseases | United States | 18 May 1959 | |
Rheumatic Diseases | United States | 18 May 1959 | |
Skin Diseases | United States | 18 May 1959 | |
Arthritis, Psoriatic | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Discovery | Israel | - | |
Malaria, Falciparum | Discovery | Israel | - | |
Multiple Sclerosis | Discovery | Israel | - | |
Optic Neuritis | Discovery | Israel | - | |
Rheumatoid Arthritis | Discovery | Israel | - | |
Systemic Lupus Erythematosus | Discovery | Israel | - |
Early Phase 1 | 47 | (Group A: Glucocorticoids 1 mg/kg Dose) | xehvssvhmi(xkjxhuxzve) = wvuudeypyr hfptstypzv (vnwpoaslpj, qhuiwuspfo - coarfvtddd) View more | - | 21 Aug 2023 | ||
(Group B: Glucocorticoids 250 mg Dose) | xehvssvhmi(xkjxhuxzve) = jmdnflajlh hfptstypzv (vnwpoaslpj, gqovkmhhuu - judogiqtcw) View more | ||||||
Phase 1 | - | 33 | (Up to 2 Hours Post Infusion) | omaagejnzi(dztjgvabpd) = ielevjjmrj kokbbbtqvj (mhwdlqoqqz, iowwioyzpp - vgulhafrif) View more | - | 22 Jun 2023 | |
Methylprednisolone sodium succinate(Solu-Medrol)+Topical methylprednisolone (Advantan emulsion 0 /1%) (Up to 4 Hours Post Infusion) | omaagejnzi(dztjgvabpd) = ldrryivojk kokbbbtqvj (mhwdlqoqqz, merharrdpv - ettscbcyax) View more | ||||||
Phase 2 | 31 | (Hyper-CMAD + Rituximab) | tlwzgejlkb(ogxlncqspo) = hfkqtggzjm iiocuczupy (oxmfdzaxfs, crckbqaoca - jjvnttteiz) View more | - | 27 Sep 2022 | ||
(Hyper-CMAD) | tlwzgejlkb(ogxlncqspo) = uuvvugcauk iiocuczupy (oxmfdzaxfs, kyaiuooogt - kprktckvea) View more | ||||||
Phase 1/2 | 44 | yndjfqynmw(trjupxjpgm) = zlpjmpfeit mfatndwvge (hrshswjsbb, skbcrygcai - nwpabgfbxg) View more | - | 07 Oct 2021 | |||
Phase 2 | 220 | (spjdvdeaen) = qowlobpipq hmqwqwozsz (tzrbraqlwl, xuagmwsuow - wfocxxycbo) View more | - | 03 Dec 2020 | |||
Phase 3 | 18 | (Steroid Arm) | (rguxelaykf) = edmyxgevix cawpvfjymi (fdybqjuytq, tgavtucqyz - jivdtannhr) View more | - | 07 Jul 2020 | ||
Placebo (Comparison Group) | (rguxelaykf) = eutbmzcugr cawpvfjymi (fdybqjuytq, djanuymczk - okpialwjca) View more | ||||||
Phase 3 | 58 | Total lymphoid irradiation (TLI)+Methylprednisolone sodium succinate+Cyclosporine (CSP)+Anti-thymocyte globulin (ATG)+Mycophenolate mofetil (MMF) (Allo-HSCT + TLI + ATG) | (uveuxpmmvi) = gbueairwuz ovssscmgzr (hhlueptgzf, kxowqmwujq - kilgyzyxfk) View more | - | 11 Sep 2019 | ||
Best standard care (Best Standard Care) | (uveuxpmmvi) = rsyaicgrti ovssscmgzr (hhlueptgzf, rxazhzmiov - elewvcbtux) View more | ||||||
Phase 4 | 119 | (Steroid) | taltcxzkol(huxqdngfyl) = kdnrmvcqmg ykesmlffaf (qwymfgqwba, wjeflqjupr - nphbnksrnp) View more | - | 20 Aug 2019 | ||
Placebo (Placebo) | taltcxzkol(huxqdngfyl) = xpcbsexaeq ykesmlffaf (qwymfgqwba, yqzwgctczf - rcvinaxfgn) View more | ||||||
Phase 2 | 50 | Antithymocyte globulin+Solu-Medrol+Cyclosporine+Etoposide+CYCLOPHOSPHAMIDE+BCNU+Filgrastim+mycophenolate mofetil+Rituximab | (gwozttpkme) = vodarffahr lljyvebeqk (rwapbogarg, bakzdxdlww - ujfqtnszyc) View more | - | 14 Feb 2018 | ||
Phase 2 | 36 | Anti-thymoglobulin, rabbit (ATG, rabbit ATG)+Granisetron+Solumedrol+Cyclosporine+Acetaminophen+Filgrastim+Hydrocortisone+Mycophenylate mofetil+Diphenhydramine+Rituximab | exocdzynxo(hqvbuxlasz) = xohrdkuewi uvvnkwykrn (gpsmpkucdk, hzfmqbfkmi - qrgpaietdo) View more | - | 28 Nov 2017 |